RecruitingPhase 3NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Studying Amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Intervention
- Acoramidis(drug)
- Enrollment
- 582 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2025 – 2032
Study locations (30)
- University of California, San Diego (UCSD) - Medical Center, La Jolla, California, United States
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles, California, United States
- University of California, San Francisco (UCSF), San Francisco, California, United States
- Stanford University, Stanford, California, United States
- University of Colorado Anschutz, Aurora, Colorado, United States
- Yale University School of Medicine - Section of Cardiology, New Haven, Connecticut, United States
- MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C., District of Columbia, United States
- Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
- Cleveland Clinic Florida, Weston, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
- University of Chicago - Medical Center, Chicago, Illinois, United States
- University of Maryland Medical Center, Baltimore, Maryland, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06563895 on ClinicalTrials.govOther trials for Amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07560306[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid CardiomyopathyBrigham and Women's Hospital
- RECRUITINGNCT07494656A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in GermanyPfizer
- RECRUITINGPHASE2NCT07285044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo Clinic
- RECRUITINGNCT07218705A Study Of MCG In Cardiac AmyloidosisMayo Clinic
- ENROLLING BY INVITATIONPHASE2NCT06723015Tau PET Outcomes With Anti-amyloid ImmunotherapiesMayo Clinic
- RECRUITINGNCT07213297Comprehensive Program for Hereditary Transthyretin AmyloidosisHospital de Alta Complejidad en Red
- RECRUITINGPHASE1NCT06790394Test-retest Study With [18F]FBB in Cardiac AmyloidosisLife Molecular Imaging GmbH
- RECRUITINGNANCT07112066Multimodality Cardiac Imaging for Disease Progression in ATTR-CMDominik Benz